Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-Depth Molecular Characterization in Marrow Failure Syndromes to Understand Clonal Dynamics and Expansion

NCT07102849 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT07102849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07102849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-Depth Molecular Characterization in Marrow Failure Syndromes to Understand Clonal Dynamics and Expansion
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 9, 2025
Completion date
July 11, 2030
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow diseases, bone marrow failure disorders, hemoglobinurea, paroxysmal, myelodysplastic syndromes, vexas syndrome